T. Rowe Price Associates’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,207,187
Closed -$75.2M 3041
2024
Q2
$75.2M Sell
2,207,187
-316,399
-13% -$9.37M 0.01% 605
2024
Q1
$88.8M Buy
2,523,586
+300,958
+14% +$10.1M 0.01% 578
2023
Q4
$64.2M Buy
2,222,628
+141,888
+7% +$3.38M 0.01% 634
2023
Q3
$47.7M Sell
2,080,740
-111,645
-5% -$5.86M 0.01% 697
2023
Q2
$126M Buy
2,192,385
+702,624
+47% +$36.7M 0.02% 487
2023
Q1
$56.1M Buy
1,489,761
+359,764
+32% +$13.3M 0.01% 654
2022
Q4
$30.2M Sell
1,129,997
-9,772
-0.9% -$267K ﹤0.01% 806
2022
Q3
$32.3M Sell
1,139,769
-108,791
-9% -$3.03M 0.01% 766
2022
Q2
$27.1M Buy
1,248,560
+135,909
+12% +$3.79M ﹤0.01% 1079
2022
Q1
$44.7M Sell
1,112,651
-33,710
-3% -$1.41M ﹤0.01% 1004
2021
Q4
$54.3M Buy
1,146,361
+126,142
+12% +$6.76M ﹤0.01% 976
2021
Q3
$57.8M Buy
1,020,219
+646,868
+173% +$39.1M 0.01% 962
2021
Q2
$21.4M Buy
373,351
+2,844
+0.8% +$156K ﹤0.01% 1286
2021
Q1
$23.4M Buy
+370,507
New +$17M ﹤0.01% 1241

Other funds holding MORF

T. Rowe Price Associates's MORF Position: Q3 2024 in Review

T. Rowe Price Associates sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 2,207,187 shares — an estimated $75.2M sold.

T. Rowe Price Associates first reported a position in MORF in Q1 2021 and held it in 14 quarters. The position peaked at $126M in Q2 2023. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

  • T. Rowe Price Associates reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 2,207,187 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $75.2M.
  • T. Rowe Price Associates first reported a position in Morphic Holding, Inc. Common Stock in Q1 2021 and held it in 14 quarters.
  • T. Rowe Price Associates's Morphic Holding, Inc. Common Stock position peaked at $126M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.